Prescribing IgG for Immunodeficiency
Sunday, March 4, 2018: 7:00 AM-8:00 AM
Hyatt, Convention Level, Celebration 3
1.00 CME/CE
Primary Discussion Leaders:
Mark Ballow, MD FAAAAI
Elena E. Perez, MD PhD FAAAAI
David M Edgar, FRCP FRCPath

Learning Objectives:
  1. Discuss how to counsel patients on the risks and benefits of IgG therapy as well as decisions regarding route and frequency of administration
  2. Discuss how to make patient specific selections, where appropriate, of immunoglobulin products and correctly write orders for IgG therapy
  3. Describe the relative importance of the characteristics of immunoglobulin products
  • AAAAI printed handout 3004.pdf (142.5 kB)
  • See more of: Session